- Home
- ANEB vs BLUE Comparison
ANEB vs BLUE Comparison
Compare ANEB & BLUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANEB
- BLUE
- Stock Information
- Founded
- ANEB 2020
- BLUE 1992
- Country
- ANEB United States
- BLUE United States
- Employees
- ANEB N/A
- BLUE N/A
- Industry
- ANEB Biotechnology: Pharmaceutical Preparations
- BLUE Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ANEB Health Care
- BLUE Health Care
- Exchange
- ANEB Nasdaq
- BLUE Nasdaq
- Market Cap
- ANEB 36.7M
- BLUE 37.6M
- IPO Year
- ANEB 2021
- BLUE 2013
- Fundamental
- Price
- ANEB $1.43
- BLUE $3.73
- Analyst Decision
- ANEB Buy
- BLUE Hold
- Analyst Count
- ANEB 1
- BLUE 8
- Target Price
- ANEB $8.00
- BLUE $48.10
- AVG Volume (30 Days)
- ANEB 25.7K
- BLUE 566.9K
- Earning Date
- ANEB 02-14-2025
- BLUE 05-08-2025
- Dividend Yield
- ANEB N/A
- BLUE N/A
- EPS Growth
- ANEB N/A
- BLUE N/A
- EPS
- ANEB N/A
- BLUE N/A
- Revenue
- ANEB N/A
- BLUE $53,120,000.00
- Revenue This Year
- ANEB N/A
- BLUE $145.10
- Revenue Next Year
- ANEB N/A
- BLUE $257.68
- P/E Ratio
- ANEB N/A
- BLUE N/A
- Revenue Growth
- ANEB N/A
- BLUE 144.50
- 52 Week Low
- ANEB $0.80
- BLUE $3.56
- 52 Week High
- ANEB $3.30
- BLUE $31.00
- Technical
- Relative Strength Index (RSI)
- ANEB 58.07
- BLUE 29.06
- Support Level
- ANEB $0.91
- BLUE $3.75
- Resistance Level
- ANEB $1.70
- BLUE $4.10
- Average True Range (ATR)
- ANEB 0.19
- BLUE 0.26
- MACD
- ANEB 0.04
- BLUE 0.05
- Stochastic Oscillator
- ANEB 65.91
- BLUE 29.31
About ANEB Anebulo Pharmaceuticals Inc.
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company, developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations.
About BLUE bluebird bio Inc.
bluebird bio Inc is a biotechnology company engaged in researching, developing, and commercializing potentially curative gene therapies for severe genetic diseases based on its proprietary lentiviral vector (LVV) gene addition platform. The Company operates in a single segment, focusing on researching, developing and commercializing potentially transformative gene therapies for severe genetic diseases.